qPCR
Diagnostics for the Real World Prepares to Launch Retooled Rapid Point-of-Care Testing Platform
Premium
The company, also known as DRW, shared early data on its forthcoming multiplex qPCR-based platform and infectious disease panels at the ESCMID global congress in Vienna.
Riken Genesis to Distribute ABL Diagnostics Infectious Disease Assays in Japan
Under the exclusive deal, Riken will distribute the Advanced Biological Laboratories subsidiary's UltraGene qPCR tests and DeepChek sequencing assays.
The firm is developing prognostic cancer tests targeting "master driver" genes that control cancer-related biological pathways.
A reference measurement procedure incorporating digital PCR can potentially be used with rare and emerging pathogens to help labs compare qPCR results, researchers said.
Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.